Compare Amphastar Pharmaceuticals Inc (AMPH) vs Direxion Daily 20 Year Treasury Bull 3X Shares (TMF) Price & Performance

AMPH trades at $18.72, down 1.58% with bearish technical signals despite oversold RSI readings. The company reported mixed Q1 2026 results with EPS of $0.42 missing estimates of $0.70, continuing a trend of recent earnings disappointments. Valuation metrics appear reasonable with P/E of 11.29 and P/B of 1.07, while profitability remains solid with 47.34% gross margins. Recent news includes a Zacks Strong Sell rating and ongoing securities law investigation.

The stock faces near-term headwinds from earnings misses and negative analyst sentiment, though current valuations provide some downside protection. Upside potential exists if the company can execute its strategic pivot to proprietary drugs and biosimilars while managing BAQSIMI discount pressures. Key risks include ongoing legal scrutiny and competitive pressures in the generic drug market.

TMF trades at $33.42, showing minimal daily movement with a slight decline of 0.06%. The technical outlook is bearish with moving averages signaling strong selling pressure, though oscillators remain neutral. Recent news highlights significant long-term underperformance, with a $10,000 investment five years ago now worth approximately $1,527, emphasizing the leveraged ETF's high-risk nature.

The outlook for TMF remains challenging due to its leveraged structure and bearish technical signals. Investment opportunities exist for short-term traders betting on bond market rebounds, but risks include daily leverage decay, interest rate volatility, and the ETF's unsuitability for long-term holdings. Caution is warranted given the amplified loss potential.